WO2007091039A8 - Production of cabergoline and novel polymorphic form thereof - Google Patents

Production of cabergoline and novel polymorphic form thereof

Info

Publication number
WO2007091039A8
WO2007091039A8 PCT/GB2007/000397 GB2007000397W WO2007091039A8 WO 2007091039 A8 WO2007091039 A8 WO 2007091039A8 GB 2007000397 W GB2007000397 W GB 2007000397W WO 2007091039 A8 WO2007091039 A8 WO 2007091039A8
Authority
WO
WIPO (PCT)
Prior art keywords
cabergoline
polymorphic form
production
novel polymorphic
novel
Prior art date
Application number
PCT/GB2007/000397
Other languages
French (fr)
Other versions
WO2007091039A2 (en
WO2007091039A3 (en
Inventor
Alan Kenneth Greenwood
Derek Mchattie
Parveen Bhatarah
Mahmood Raza
Original Assignee
Resolution Chemicals Ltd
Alan Kenneth Greenwood
Derek Mchattie
Parveen Bhatarah
Mahmood Raza
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Resolution Chemicals Ltd, Alan Kenneth Greenwood, Derek Mchattie, Parveen Bhatarah, Mahmood Raza filed Critical Resolution Chemicals Ltd
Priority to EP07705129A priority Critical patent/EP2007761A2/en
Priority to AU2007213571A priority patent/AU2007213571A1/en
Priority to CA002640081A priority patent/CA2640081A1/en
Priority to JP2008553820A priority patent/JP2009526030A/en
Priority to BRPI0707161-2A priority patent/BRPI0707161A2/en
Publication of WO2007091039A2 publication Critical patent/WO2007091039A2/en
Publication of WO2007091039A3 publication Critical patent/WO2007091039A3/en
Priority to IL192870A priority patent/IL192870A0/en
Publication of WO2007091039A8 publication Critical patent/WO2007091039A8/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

The present application relates to a novel polymorphic form of cabergoline comprising cabergoline and t-amyl methyl ether, designated Form TAME cabergoline, together with a novel method of producing cabergoline.
PCT/GB2007/000397 2006-02-08 2007-02-06 Production of cabergoline and novel polymorphic form thereof WO2007091039A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
EP07705129A EP2007761A2 (en) 2006-02-08 2007-02-06 Production of cabergoline and novel polymorphic form thereof
AU2007213571A AU2007213571A1 (en) 2006-02-08 2007-02-06 Production of cabergoline and novel polymorphic form thereof
CA002640081A CA2640081A1 (en) 2006-02-08 2007-02-06 Production of cabergoline and novel polymorphic form thereof
JP2008553820A JP2009526030A (en) 2006-02-08 2007-02-06 CABERGOLINE AND METHOD FOR PRODUCING NOVEL POLYMORPHIM FORM
BRPI0707161-2A BRPI0707161A2 (en) 2006-02-08 2007-02-06 cabergoline production and its new polymorphic forms
IL192870A IL192870A0 (en) 2006-02-08 2008-07-17 A polymorphic form of cabergoline and methods for the production thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0602557.1A GB0602557D0 (en) 2006-02-08 2006-02-08 Production of cabergoline and novel polymorphic form thereof
GB0602557.1 2006-02-08

Publications (3)

Publication Number Publication Date
WO2007091039A2 WO2007091039A2 (en) 2007-08-16
WO2007091039A3 WO2007091039A3 (en) 2007-10-18
WO2007091039A8 true WO2007091039A8 (en) 2008-11-13

Family

ID=36119736

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2007/000397 WO2007091039A2 (en) 2006-02-08 2007-02-06 Production of cabergoline and novel polymorphic form thereof

Country Status (9)

Country Link
EP (1) EP2007761A2 (en)
JP (1) JP2009526030A (en)
CN (1) CN101384589A (en)
AU (1) AU2007213571A1 (en)
BR (1) BRPI0707161A2 (en)
CA (1) CA2640081A1 (en)
GB (1) GB0602557D0 (en)
IL (1) IL192870A0 (en)
WO (1) WO2007091039A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2525104A1 (en) 2003-05-08 2004-11-25 Ivax Pharmaceuticals S.R.O. Polymorphs of cabergoline
US7939665B2 (en) * 2007-05-04 2011-05-10 Apotex Pharmachem Inc. Efficient process for the preparation of cabergoline and its intermediates

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526892A (en) * 1981-03-03 1985-07-02 Farmitalia Carlo Erba, S.P.A. Dimethylaminoalkyl-3-(ergoline-8'βcarbonyl)-ureas
WO2002085902A1 (en) * 2001-04-16 2002-10-31 Finetech Laboratories Ltd. Process and intermediates for production of cabergoline and related compounds
IL155545A (en) * 2003-04-21 2009-12-24 Finetech Pharmaceutical Ltd Solvate form of cabergoline
CA2525104A1 (en) * 2003-05-08 2004-11-25 Ivax Pharmaceuticals S.R.O. Polymorphs of cabergoline

Also Published As

Publication number Publication date
AU2007213571A1 (en) 2007-08-16
BRPI0707161A2 (en) 2011-04-26
WO2007091039A2 (en) 2007-08-16
IL192870A0 (en) 2009-02-11
EP2007761A2 (en) 2008-12-31
CN101384589A (en) 2009-03-11
CA2640081A1 (en) 2007-08-16
GB0602557D0 (en) 2006-03-22
WO2007091039A3 (en) 2007-10-18
JP2009526030A (en) 2009-07-16

Similar Documents

Publication Publication Date Title
HK1109915A1 (en) Method for producing 1,3-propanediol using crude glycerol, a by-product from biodiesel production 13-
MX2007011668A (en) Self-adhesive addition cross linking silicon-rubber blends, method for the production thereof, method for producing composite moulded parts and the use thereof.
WO2009054373A1 (en) Method for producing cellulose ether derivative
EP2592084B8 (en) Process for producing pyripyropene derivatives and intermediates for the production thereof.
WO2007093627A3 (en) Biocidal composition
EP2222860B8 (en) Method of modifying a yeast cell for the production of ethanol
IL204555A0 (en) (carboxylalkylene-phenyl) phenyl-oxalamides, method for the production thereof, and use of same as a medicatment
IL200444A0 (en) Fluorine-containing pyrazolecarbonitrile derivative and method for producing the same, and fluorine-containing pyrazolecarboxylic acid derivative obtained by using the fluorine-containing pyrazolecarbonitrile derivative and method for producing the same
WO2008121616A3 (en) Antibodies with decreased deamidation profiles
WO2006089540A3 (en) Method for producing an optical, radiation-emitting component and optical, radiation-emitting component
EP2194093B8 (en) Resin composition, molding resin composition prepared by using the same, laminates, and process for the production of laminates
WO2009036281A3 (en) Bortezomib and process for producing same
WO2008059223A3 (en) Process for the synthesis of moxifloxacin hydrochloride
ZA201001999B (en) Set of blanks, box and production method
PL2018414T3 (en) A continuous method of producing a mash extract
WO2007021677A3 (en) Method of making a fuel cell component using an easily removed mask
PL386026A1 (en) Escitalopram production method
WO2007100512A3 (en) Methods for producing glass compositions
AP2277A (en) Process for production of 1,2,2,2-tertafluoro ethyl difluoro methyl ether.
EP1995237A4 (en) Method for producing aminoacetylpyrrolidinecarbonitrile derivative and production intermediate thereof
WO2007091039A8 (en) Production of cabergoline and novel polymorphic form thereof
GB0617763D0 (en) Cultivation of sweet sorghum for bioethanol production
EP2011781A4 (en) Process for production of indene derivative, and intermediate for production of the derivative
WO2009057938A3 (en) Method of preparing (6r)-3-hexyl-4-hydroxy-6-undecyl-5,6-dihydropyran-2-one, and intermediate used in the method
EP2177566A4 (en) Method for production of water-absorbable resin, and water-absorbable resin produced by the method

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 192870

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 569904

Country of ref document: NZ

Ref document number: 2007213571

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2640081

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 3110/KOLNP/2008

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 200780004754.2

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2008553820

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007705129

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2007213571

Country of ref document: AU

Date of ref document: 20070206

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2007213571

Country of ref document: AU

ENP Entry into the national phase

Ref document number: PI0707161

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20080721